Sebastian Jugl,
PhD Student
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 871-2678
Business Email:
s.jugl@ufl.edu
Teaching Profile
Courses Taught
2024
PHA5223 P-Epidem Drug Safety
2025
PHA5244 Prin Evid Based Prac
Publications
Academic Articles
2025
Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient.
Cannabis and cannabinoid research.
10(2):207-212
[DOI] 10.1089/can.2024.0073.
[PMID] 39375043.
2024
Cannabis use and acute postoperative pain outcomes in older adults: a propensity matched retrospective cohort study.
Regional anesthesia and pain medicine.
[DOI] 10.1136/rapm-2024-105633.
[PMID] 38950932.
2024
Cannabis Use and Inhalational Anesthesia Administration in Older Adults: A Propensity-matched Retrospective Cohort Study.
Anesthesiology.
141(5):870-880
[DOI] 10.1097/ALN.0000000000005146.
[PMID] 38980341.
2024
Prenatal Exposure to Valproic Acid Across Various Indications for Use.
JAMA network open.
7(5)
[DOI] 10.1001/jamanetworkopen.2024.12680.
[PMID] 38776082.
2024
Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey.
Medical cannabis and cannabinoids.
7(1):138-148
[DOI] 10.1159/000540593.
[PMID] 39474237.
2023
Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain.
Medical cannabis and cannabinoids.
6(1):41-45
[DOI] 10.1159/000530251.
[PMID] 37124080.
2023
Developing and validating a natural language processing algorithm to extract preoperative cannabis use status documentation from unstructured narrative clinical notes.
Journal of the American Medical Informatics Association : JAMIA.
30(8):1418-1428
[DOI] 10.1093/jamia/ocad080.
[PMID] 37178155.
2023
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
JAMA.
330(4)
[DOI] 10.1001/jama.2023.8888.
[PMID] 37490092.
2023
Protocol of a Combined Cohort and Cross-Sectional Study of Persons Receiving Medical Cannabis in Florida, USA: The Medical Marijuana and Me (M3) Study.
Medical cannabis and cannabinoids.
6(1):46-57
[DOI] 10.1159/000530052.
[PMID] 37261066.
2022
Clinical Considerations for Cannabis Use and Cardiovascular Health.
Medical cannabis and cannabinoids.
5(1):120-127
[DOI] 10.1159/000526731.
[PMID] 36467784.
2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.
Medical cannabis and cannabinoids.
4(1):21-42
[DOI] 10.1159/000515069.
[PMID] 34676348.
2021
Letter by Sarayani et al Regarding Article, “Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque”.
Circulation.
143(25):e1031-e1032
[DOI] 10.1161/CIRCULATIONAHA.120.052678.
[PMID] 34152796.
2021
Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit.
Medical cannabis and cannabinoids.
4(2):121-124
[DOI] 10.1159/000517154.
[PMID] 35224432.
2021
Practice Patterns and Training Needs Among Physicians Certifying Patients for Medical Marijuana in Florida.
Journal of primary care & community health.
12
[DOI] 10.1177/21501327211042790.
[PMID] 34452585.
2021
Priorities for Medical Marijuana Research from the Perspective of Physicians, Dispensary Owners/Staff, and Patients: A Survey Study.
Medical cannabis and cannabinoids.
4(2):107-113
[DOI] 10.1159/000518105.
[PMID] 35224430.
Contact Details
Phones:
- Business:
- (352) 871-2678
Emails:
- Business:
- s.jugl@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610